{
  "ticker": "REGN",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 19,
  "transactions": [
    {
      "id": 214446,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-17",
      "transaction_shares": "500",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23338"
    },
    {
      "id": 214398,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-12",
      "transaction_shares": "800",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "23406"
    },
    {
      "id": 214432,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-04",
      "transaction_shares": "500",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "22948"
    },
    {
      "id": 214455,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Fenimore Christopher R.",
      "reporting_owner_cik": "0001697422",
      "reporting_owner_position": "SVP Controller",
      "transaction_date": "2024-01-03",
      "transaction_shares": "5000",
      "transaction_price": "555.67",
      "transaction_type": "M",
      "shares_after_transaction": "19372"
    },
    {
      "id": 214472,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "LAROSA JOSEPH J",
      "reporting_owner_cik": "0001238303",
      "reporting_owner_position": "EVP General Counsel and Secret",
      "transaction_date": "2024-01-03",
      "transaction_shares": "34000",
      "transaction_price": "399.66",
      "transaction_type": "M",
      "shares_after_transaction": "64036"
    },
    {
      "id": 214335,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "COLES N ANTHONY",
      "reporting_owner_cik": "0001197018",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1393"
    },
    {
      "id": 214348,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "SING GEORGE L",
      "reporting_owner_cik": "0001225471",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "26349"
    },
    {
      "id": 214353,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Schenkein David P",
      "reporting_owner_cik": "0001578200",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "42",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "282"
    },
    {
      "id": 214355,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "GOLDSTEIN JOSEPH L",
      "reporting_owner_cik": "0001225474",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "6382"
    },
    {
      "id": 214356,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Bassler Bonnie L",
      "reporting_owner_cik": "0001683607",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1382"
    },
    {
      "id": 214371,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "BROWN MICHAEL S",
      "reporting_owner_cik": "0001174475",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "1382"
    },
    {
      "id": 214372,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Thompson Craig B.",
      "reporting_owner_cik": "0001423419",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "454"
    },
    {
      "id": 214375,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Landry Robert E",
      "reporting_owner_cik": "0001585160",
      "reporting_owner_position": "EVP Finance CFO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "650",
      "transaction_price": "378.98",
      "transaction_type": "M",
      "shares_after_transaction": "22457"
    },
    {
      "id": 214444,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "RYAN ARTHUR F",
      "reporting_owner_cik": "0001187443",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "1",
      "transaction_price": "873.91",
      "transaction_type": "S",
      "shares_after_transaction": "18446"
    },
    {
      "id": 214445,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Guarini Kathryn",
      "reporting_owner_cik": "0001992352",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "42",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "282"
    },
    {
      "id": 214454,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "Zoghbi Huda Y",
      "reporting_owner_cik": "0001681643",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "1117",
      "transaction_price": "391.92",
      "transaction_type": "M",
      "shares_after_transaction": "2364"
    },
    {
      "id": 214463,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "YANCOPOULOS GEORGE",
      "reporting_owner_cik": "0001226690",
      "reporting_owner_position": "Bd. Co-Chair, President & CSO",
      "transaction_date": "2024-01-02",
      "transaction_shares": "16848",
      "transaction_price": "900.0",
      "transaction_type": "S",
      "shares_after_transaction": "180000"
    },
    {
      "id": 214465,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "McCourt Marion",
      "reporting_owner_cik": "0001663758",
      "reporting_owner_position": "EVP Commercial",
      "transaction_date": "2024-01-02",
      "transaction_shares": "274",
      "transaction_price": "873.91",
      "transaction_type": "S",
      "shares_after_transaction": "15062"
    },
    {
      "id": 214483,
      "issuer_name": "REGENERON PHARMACEUTICALS, INC.",
      "reporting_owner": "POON CHRISTINE A",
      "reporting_owner_cik": "0001189014",
      "reporting_owner_position": null,
      "transaction_date": "2024-01-02",
      "transaction_shares": "135",
      "transaction_price": "0.0",
      "transaction_type": "A",
      "shares_after_transaction": "2172"
    }
  ]
}